drugset / Trial / NCT02058290

A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy

NCT02058290

Phase 4 Terminated 122 enrolled Pacira Pharmaceuticals, Inc Registrat-Mapi · collab
Non-randomizedParallel-groupOpen-labelHealth-services research

Summary

This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospital costs.

Timeline

Start
2011-12
Primary completion
2012-09
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 266 mg Other
Comparator Morphine Other / unclassified Intravenous
Background Ketorolac Other / unclassified 30 mg Intravenous